- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01135407
Visual Selective Attention in Parkinson's Disease (VSA-PD)
Role of the Cortico-basal Ganglia Loops in Visual Attention: Effects of Dopaminergic and Subthalamic Nucleus Stimulation in Parkinson's Disease
Parkinson's disease (PD), which is generally considered to be a motor disorder, is now known to be accompanied in many instances by a variety of cognitive defects. This can be explained considering that PD is a neurodegenerative and progressive disorder of the basal ganglia system, which works modulating not only motor, but also cognitive and emotional behaviours.
Concerning this, some studies suggest that non-demented PD patients may suffer from a voluntary selective visual attention orienting deficit, showing a reduced skill in focusing upon one target, and may be easily distracted from irrelevant but salient stimuli, with a consequent negative impact on their physical health, social interactions and quality of life.
Up to now, the evidence of the role of the basal-ganglia system in modulating visual attention functions is poor and indirect and the effects of dopaminergic and subthalamic nucleus (STN) stimulation (two usual and effective treatments in PD) on attention performances are controversial.
The main objectives of the project are: 1) to assess the visual selective attention as well as the distractibility in PD patients; 2) to study the effects of patient's usual antiparkinsonian treatments, that is dopaminergic and STN stimulation, on visual attention performances.
Secondly, from a clinical and neurophysiologic point of view, the investigators want to study the respective role of the dopaminergic pathways and the sensorimotor and associative/limbic cortico-basal ganglia loops passing across the STN in the visual attention performances.
To precisely answer the objectives of the protocol, the investigators will record the performances of participants during the administration of 3 computerized tests, which are suitable to study visual attention, decision making and motor performances.
The investigators will compare the performances on the computerized tests of two groups of PD patients, one evaluated in different sets of electrical (without stimulation, or selective stimulation of the sensorimotor or associative/limbic part of the STN) stimulation, the other in different conditions of medication (with or without dopaminergic treatment) with those of a group of healthy subjects.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Grenoble, France, 38043
- Unité des Troubles du Mouvement, Clinique de Neurologie, Grenoble University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
PD patients and healthy controls will be matched for age, sex, and education. PD patients: group #1 e group #2
Inclusion Criteria:
- Idiopathic Parkinson's Disease at a disease's stage characterized by motor complications
- Able to tolerate a prolonged condition without medication
- Levodopa response > 30% (for group #1)
- Self-declared normal or corrected to normal vision
- At least one contact lead in the sensorimotor part and another contact in the associativelimbic part of the STN (for group #2).
- Patients with a healthy social security affiliation
- Able to give and sign the informed consent
Exclusion Criteria:
- Patients under guardianship, interdicted, or under administrative measures and legal constraints
- Fertile women not using adequate contraceptive methods
- Women who are pregnant or breast feeding
- Severe cognitive impairment
- Severe frontal executive functions impairment
- Actual psychotic disorders
- Major depression
- Motivation impairment
- Any medical or psychological problems which may interfere with a smooth conduction of the study protocol
- Significant deficiency in red-green color discrimination
- Drug or alcohol addiction
Healthy controls: group #3
Inclusion Criteria:
- Self-declared neurologically healthy subjects,
- Self-declared normal or corrected to normal vision
- No psychotropic or neurotrophic drugs intake
- Subjects with a healthy social security affiliation
- Able to give and sign the informed consent
Exclusion Criteria:
- Patients under guardianship, interdicted, or under administrative measures and legal constraints
- Fertile women not using adequate contraceptive methods
- Women who are pregnant or breast feeding
- Severe cognitive impairment
- Severe frontal executive functions impairment
- Actual psychotic disorders
- Major depression
- Motivation impairment
- Any medical or psychological problems which may interfere with a smooth conduction of the study protocol
- Significant deficiency in red-green color discrimination
- Drug or alcohol addiction
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
group #1
Parkinson's disease patients at a disease's stage characterized by motor complications
|
Patients will perform more than one experimental session. In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented. During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals. The computerized tests are administered in two different conditions of medication: with or without dopaminergic treatment, corresponding to two different experimental sessions.
Patients will perform more than one experimental session.
In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented.
During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals.
The computerized tests are administered in three different sets of electrical (without stimulation, or selective stimulation of the sensorimotor or associative/limbic part of the subthalamic nucleus) stimulation, corresponding to three different experimental sessions.
Participants will perform more than one experimental session.
In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented.
During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals.The computerized tests are administered twice (in two different experimental sessions) to verify the performance repeatability.
|
group #2
Parkinson's disease patients treated by subthalamic nucleus deep brain stimulation.
|
Patients will perform more than one experimental session. In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented. During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals. The computerized tests are administered in two different conditions of medication: with or without dopaminergic treatment, corresponding to two different experimental sessions.
Patients will perform more than one experimental session.
In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented.
During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals.
The computerized tests are administered in three different sets of electrical (without stimulation, or selective stimulation of the sensorimotor or associative/limbic part of the subthalamic nucleus) stimulation, corresponding to three different experimental sessions.
Participants will perform more than one experimental session.
In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented.
During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals.The computerized tests are administered twice (in two different experimental sessions) to verify the performance repeatability.
|
group #3
healthy controls
|
Patients will perform more than one experimental session. In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented. During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals. The computerized tests are administered in two different conditions of medication: with or without dopaminergic treatment, corresponding to two different experimental sessions.
Patients will perform more than one experimental session.
In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented.
During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals.
The computerized tests are administered in three different sets of electrical (without stimulation, or selective stimulation of the sensorimotor or associative/limbic part of the subthalamic nucleus) stimulation, corresponding to three different experimental sessions.
Participants will perform more than one experimental session.
In each experimental session 3 computerized tasks, which are suitable to study visual attention, decision making and motor performances will be presented.
During these tests, participants have to responds the most quickly and accurately possible to the appearance on a computer display of a predetermined target stimuli, presented alone or in an array of signals.The computerized tests are administered twice (in two different experimental sessions) to verify the performance repeatability.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
reaction time in trials of the computerized tests
Time Frame: 1 hour for each experimental session. All participants will perform more than one experimental session, on different days within the same week
|
Reaction times is recorded during one hour sessions for each patient/control subject (for more details see the Intervention Section)
|
1 hour for each experimental session. All participants will perform more than one experimental session, on different days within the same week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
responses accuracy in trials of the computerized tests
Time Frame: 1 hour for each experimental session. All participants will perform more than one experimental session, on different days within the same week
|
responses accuracy is recorded during one hour sessions for each patient/control subject (for more details see the Intervention Section)
|
1 hour for each experimental session. All participants will perform more than one experimental session, on different days within the same week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Pierre POLLAK, Professor, Unité des Troubles du Mouvement, Clinique de Neurologie, Grenoble University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0914
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Attention in Parkinson's Disease
-
University of California, Santa BarbaraNational Eye Institute (NEI)Not yet recruitingAttention | Basic Science: Visual Attention in Healthy Participants | Basic Science: Neural Representations of LocationUnited States
-
University of California, Santa BarbaraNational Eye Institute (NEI)RecruitingBasic Science: Visual Attention in Healthy Participants | Basic Science: Neural Representations of LocationUnited States
-
Brigham and Women's HospitalRecruitingIncidental Findings | Visual Attention | Visual Search | Hybrid SearchUnited States
-
Stanford UniversityNational Eye Institute (NEI)Enrolling by invitationRepetitive Transcranial Magnetic Stimulation | Visual Attention | Visual Cortical PlasticityUnited States
-
University of California, BerkeleyCompletedAttention | Visual Perception | Information Processing | Cholinergic SystemUnited States
-
University College CorkUniversity of UlsterUnknown
-
China Medical University HospitalCompletedVisual Sensitivity in NewbornsTaiwan
-
Herlev HospitalCompletedCognition and Attention in Surgeons and NursesDenmark
-
Sheba Medical CenterWithdrawnAttention Deficit Disorder With Hyperactivity | Attention-Deficit Disorder in Adolescence
-
Institut National de la Santé Et de la Recherche...CompletedReaction Time | Awareness | Change in Sustained AttentionFrance
Clinical Trials on Recording during computerized tests
-
Duke UniversityNational Institute on Aging (NIA); Bryan Alzheimer's Disease Research Center; Duke University Center for the Study of Aging and Human DevelopmentCompleted
-
University Hospital, AngersInstitut de Formation en Education Physique et en Sport d'Angers/Les Ponts... and other collaboratorsCompletedHealthy VolunteersFrance
-
BrainScope Company, Inc.RecruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
Centre Hospitalier Universitaire, AmiensCompletedStroke | Parkinson's Disease | Alzheimer Disease | Huntington Disease | Lewy Body DementiaFrance
-
Medical University of ViennaAustrian Science Fund (FWF)Active, not recruitingHeart Failure | Artificial Heart Device UserAustria
-
University Hospital, AngersSociété Française de Médecine VasculaireCompletedPeripheral Arterial DiseaseFrance
-
Guy's and St Thomas' NHS Foundation TrustUniversity of Oxford; Engineering and Physical Sciences Research Council, UKCompleted
-
Maxima Medical CenterNot yet recruitingIliac Artery Occlusion | Iliac Artery Disease | Iliac Artery Stenosis | Near-Infrared Spectroscopy
-
Frank LobbezooCompletedSleep Bruxism | Dental Implant ComplicationsNetherlands
-
Istanbul University - Cerrahpasa (IUC)CompletedMultiple Sclerosis | Gait Disorders, Neurologic | Upper Extremity ProblemTurkey